skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: What do you think of this company and life sciences real estate. Institutional money is starting to flow into the space - wondering if this company is a good buy/how is is valued.

Also, do you know any other ways to get exposure to life sciences real estate or data centres?
Read Answer Asked by Max on June 21, 2021
Q: Hi Team,
Can you suggest one or two US Pharma company for a long term holding Please !
Thanks as always,
Tak
Read Answer Asked by Tak on June 18, 2021
Q: I own both ABBV and MDT and I am up nicely on both, thanks to 5i.
Thinking of selling MDT and purchasing SYK, which should have more growth in the coming months??
I would appreciate your opinion on all companies and the switch from MDT to SYK.

Thanks

Dave.
Read Answer Asked by David on June 17, 2021
Q: Could i have your opinion on Applied Therapeutics ?
Read Answer Asked by Richard on June 16, 2021
Q: Of the 3, which do you see with greatest growth potential? Is there any overlap in owning all 3 that would make one expendable?
Read Answer Asked by Todd on June 16, 2021
Q: Good day - thank you for reading my email and all your information and prompt assistance It is very appreciated

Would you please suggest which stocks you would buy in healthcare and consumer defensive - Canadian and US if possible
Read Answer Asked by Marla on June 15, 2021
Q: Hello 5i,
Income value investor with some growth stocks. Just received 16 shares of OGN. At 75 years I don't think I want to wait for "maybe" some growth. No dividend either. I would just sell them and by a few more MRK. Any suggestions would be appreciated.
Stanley
Read Answer Asked by STANLEY on June 11, 2021
Q: can you recommend a Canadian and Us biotech etf and stock?
thanks
Read Answer Asked by Mary on June 10, 2021
Q: Hi guys
Had a pleasant surprise today, for a change, a company that I had written off, started trading today after a long halt, change of business, it is trading at $ ,70 or so, my cost base is $.35, can you tell me something about this one, how does the future look, should I blow it out, or hold on, in your opinion.
thanks for your time and keep safe
Auftar
Read Answer Asked by auftar on June 09, 2021
Q: Could you provide any up- dated assessment you may have re. Novo Nordisk in light of FDA approval of their obesity drug Wegovy. The monthly cost of a regimen of the drug is apparently $800.00 ( without insurance ) . But with 100 million obese Americans and obesity increasing risk factors for many other diseases, might it be a reasonable speculation that insurers may cover the drug at some point. Any sense of how much of this potential might be already factored in and how much might be a potential game changer if it plays out successfully over time?
Thank-you
Read Answer Asked by William on June 09, 2021